Titlebook: Carcinoma of the Prostate; Innovations in Manag Zbigniew Petrovich (Professor, Department of Radia Book 1996 Springer-Verlag Berlin Heidelb

Institution

Radical Retropubic Prostatectomy: The USC Experience, al. 1995). It has been estimated that 244 000 new cases of prostate cancer will be diagnosed in the United States in 1995, resulting in 40 400 prostate cancer deaths during the same period (. et al. 1995). This estimate represents a 100% increase in new cases of prostate cancer when compared with 1

異端

勤勞

The Role of Prostate-Specific Antigen in the Management of Prostate Cancer,atic acid phosphatase (PAP), prostate-specific antigen (PSA), prostate-specific protein (PSP-94), and human kallikrein 2 (hK2) (Table 14.1). At the present time the biochemical and pathologic mechanisms for the entry of these proteins into the systemic circulation are not well understood.

AIL

做作

Localized Carcinoma of the Prostate: Patterns of Failure with External Beam Radiation Therapy,n most institutions, in the majority of patients with stage C or more locally extensive tumors (. et al. 1993a). Tumor doses have ranged from 60 to 64 Gy for stage Al (T1a), 65 to 70 Gy for stage A2 (T1b) and B (T2), and 66 to 72 Gy for stage C (T3) tumors. Several retrospective studies indicate tha

considerable

External Beam Radiotherapy for Localized Prostatic Cancer at Stanford: Update at the 38th Year, treatment of prostatic cancer. Since then, a wide variety of radiation sources have been used in the treatment of this neoplasm (Table 17.1) (. 1993). Currently, external beam x-irradiation derived from mid- to high-energy linear accelerators (6–25 MV) is the most widely employed modality, although

表兩個

匍匐前進

Treatment-Related Complications in Patients with Carcinoma of the Prostate: a Review,cal control and overall survival. However, with the variability of the natural history of this disease process, it is often difficult to assess the impact of the various treatment modalities on the disease course. Therefore, the optimal treatment modality remains controversial. While anticipated con

Mucosa

,Critical Points of?Functionals,amatic increase in prostate cancer detection. While controversy still exists in the literature regarding the benefits of routine screening for prostate cancer, it is becoming standard practice amongst physicians to screen men over 50 years of age for prostate cancer on a yearly basis using both digital rectal examination (DRE) and serum PSA.

放逐某人

Autonomous Nonlinear Functional Evolutions,d morbidity and subsequent quality of life are also extremely important. Therefore, with 244 000 new cases of prostate carcinoma anticipated in the United States in 1995, assessment of the treatment results must take into account the morbidity of a particular therapeutic regimen.